Navigation Links
Sinovac's CEO Weidong Yin Nominated for China Central Television's Prestigious Economic Man-of-the-Year Award

BEIJING, Dec. 15 /PRNewswire-Asia/ -- Sinovac Biotech Ltd. ( SVA), a leading provider of biopharmaceutical products in China, announced today that Weidong Yin, Chairman, President & CEO, was selected by China Central Television (CCTV) to be one of 18 nominees for China's 2009 Economic Man-of-the-Year.

CCTV's Economic Man-of-the-Year is the country's most influential and well-known business award, sometimes referred to as the "Oscar Award of the Chinese Economy." The award is granted to those business leaders who exemplify China's economic growth, are central to the Chinese economy in the current year, and represent role models of the Chinese economy.

Mr. Weidong Yin, Chairman, President and CEO of Sinovac, remarked, "For me, it's unexpected to be nominated for China's 2009 Economic Man-of-the-Year. And I am pleased to have it on my personal record. It also demonstrates that the contributions made by Sinovac, represented by me, to Chinese society has been recognized and appreciated by the public. Sinovac's management will continue to execute our business development strategy in this favorable environment and we are confident on our performance and growth. We will continue to make efforts to maximize our shareholders' interests."

The award's criteria include creativity, driving force, vision, and social responsibility. The nominees include Yu Minhong (Michael Yu), CEO of New Oriental Group and Cao Guowei (Charles Chao), CEO of, among others. The final results will be announced on Dec. 23, 2009. Winners are chosen by a panel of expert judges, aided by votes from the public via the Internet.

Previous recipients of the Economic Man-of-the-Year award included Lin Yifu, World Bank Senior Vice President and Chief Economist; Liu Chuanzhi, Chairman of Lenovo; and Li Yanhong (Robin Li), president of

About Sinovac

Sinovac Biotech Ltd. is a China-based biopharmaceutical company that focuses on the research, development, manufacture and commercialization of vaccines that protect against human infectious diseases. Sinovac's vaccine products include Healive(R) (hepatitis A), Bilive(R) (combined hepatitis A and B), and Anflu(R) (influenza). Panflu(R) and PANFLU.1(TM), Sinovac's pandemic influenza vaccine (H5N1) and H1N1 vaccine, have already been approved for government stockpiling. Sinovac is developing vaccines for enterovirus 71, universal pandemic influenza, Japanese encephalitis, and human rabies. Its wholly owned subsidiary, Tangshan Yian, is conducting field trials for independently developed inactivated animal rabies vaccine.

Safe Harbor Statement

This announcement contains forward-looking statements. These statements are made under the "safe harbor" provisions of the U.S. Private Securities Litigation Reform Act of 1995. These forward-looking statements can be identified by words or phrases such as "will," "expects," "anticipates," "future," "intends," "plans," "believes," "estimates" and similar statements. Among other things, the business outlook and quotations from management in this press release contain forward-looking statements. Statements that are not historical facts, including statements about Sinovac's beliefs and expectations, are forward-looking statements. Forward-looking statements involve inherent risks and uncertainties. A number of important factors could cause actual results to differ materially from those contained in any forward-looking statement. Sinovac does not undertake any obligation to update any forward-looking statement, except as required under applicable law.

    For more information, please contact:

     Helen G. Yang
     Sinovac Biotech Ltd.
     Tel:   +86-10-8289-0088 x9871
     Fax:   +86-10-6296-6910

     Amy Glynn/Stephanie Carrington
     The Ruth Group
     Tel:   +1-646-536-7023/7017

     Janine McCargo
     The Ruth Group
     Tel:   +1-646-536-7033

SOURCE Sinovac Biotech Ltd.

SOURCE Sinovac Biotech Ltd.
Copyright©2009 PR Newswire.
All rights reserved

Related medicine technology :

1. China Yongxin Pharmaceuticals, Inc. Announces Results for the Third Quarter Ended September 30, 2009
2. China-Biotics, Inc. to Hold 2009 Annual Meeting of Stockholders on March 5, 2010
3. BMP Sunstone Announces the Inclusion of Seventy Eight Drugs in Chinas National Insurance Catalog
4. China Biologic Products Approved to List on NASDAQ
5. China Sky One Medical, Inc. Achieved Progress in the Development of Two New Biological Testing Kits
6. Lotus Pharmaceuticals, Inc. to Exhibit at the 62nd PHARMCHINA
7. China Sky One Medical, Inc. Announces Record Third Quarter 2009 Results
8. China Medicine Announces Strong Third Quarter 2009 Results
9. Chindex International Announces Participation in Brean Murray, Carret & Co. 2009 China Growth Conference
10. China National Medicines Corporation Issues Milestone Purchase Order for 12,000 STA Systems
11. China Medicine Corporation to Acquire Pharmaceutical Manufacturer in Guangzhou
Post Your Comments:
(Date:11/24/2015)... -- Teledyne DALSA , a Teledyne Technologies company and ... its CMOS X-Ray detector for mammography at the ... 3, at McCormick Place in Chicago . ... imaging will be on display in the South Hall, Booth ... X-Ray detectors is the industry benchmark for high speed imaging ...
(Date:11/24/2015)... , Nov. 24, 2015  Boston Scientific Corporation (NYSE: ... Oppenheimer 26th Annual Healthcare Conference on December 8, in ... Susie Lisa , vice president, Investor Relations, will participate ... beginning at approximately 8:35 a.m. ET. --> ... in a 30-minute question-and-answer session with the host analyst ...
(Date:11/24/2015)... 2015   Renowned ... deliver s advice and insights on supplements ... More than 50% of Dubai ... to the DHA   femMED launches comprehensive solutions for women ... Dubai residents are not consuming enough to keep themselves ...
Breaking Medicine Technology:
(Date:11/25/2015)... (PRWEB) , ... November 25, 2015 , ... ... for Tuberous Sclerosis Complex (TSC), as well as raising public awareness of the ... they need it—presented a third donation of $35,000 to bolster progress at the ...
(Date:11/25/2015)... ... 25, 2015 , ... Bunion Bootie , the newest ... of the early holiday shopping season. Starting Wednesday November 25th, Bunion Booties are ... Friday promotional pricing is in addition to any automatic discounts applied when buying ...
(Date:11/24/2015)... ... ... Dr. Todd S. Afferica, a noted general dentist in Norcross, GA ... Afferica now uses the BIOLASE WaterLase iPlus 2.0™ in many of his dental procedures. ... traditional cutting tools, such as the scalpel and high-speed drill, which can both cause ...
(Date:11/24/2015)... ... , ... Charitable giving is at its peak during the holidays. In ... of the year totalling over $358 billion in 2014. With more than 1.5 ... those individuals who want to “give back” during the holidays. , “With so many ...
(Date:11/24/2015)... (PRWEB) , ... November 25, 2015 , ... ... technologies and development solutions for drugs, biologics, consumer health and global clinical supply ... present at the upcoming Clinical Trial Supply East Asia Conference, to be held ...
Breaking Medicine News(10 mins):